Caterina Soldà

Istituto Oncologico Veneto

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Alessandro Zerbi

Humanitas University

ITALY

View details

LUCA TONDULLI

Head of Medical Oncology

Provincia autonoma di Bolzano - Alto Adige

ITALY

View details

Matteo Fassan

ITALY

View details

Marco Scarpa

ITALY

View details

FRANCESCO TOVOLI

Assistant Professor

University of Bologna

ITALY

View details

Ornella Garrone

Head

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Caterina Soldà

Research Interests

Explore related searches

Contact this professor

Articles (9)

Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis

Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?

Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis

Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.

Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma.

Clinical relevance of pancreatic enzyme replacement therapy (PERT) in patients affected by advanced pancreatic ductal adenocarcinoma (PDAC) undergoing first-line chemotherapy

Organizational challenges and oncological activity volumes during the SARS-CoV-2 epidemic peak in Verona, Italy

Sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT): Prevalence and clinical implications

Collaborators (6)

Alessandro Zerbi

LUCA TONDULLI

Matteo Fassan

Marco Scarpa

FRANCESCO TOVOLI

Ornella Garrone

Make your next move.